MedPath
TGA Product

APO-MOMETASONE NASAL ALLERGY RELIEF mometasone furoate 50 micrograms / actuation aqueous nasal spray

Product approved by Therapeutic Goods Administration (AU)

Basic Information

APO-MOMETASONE NASAL ALLERGY RELIEF mometasone furoate 50 micrograms / actuation aqueous nasal spray

Regulatory Information

206495

February 28, 2013

Medicine

Medicine

RE

Active

Company Information

Active Ingredients

Detailed Information

Summary

https://medical-cdn.nocode.com/drug_tga/9efc9b1d4fa23d29bbdeb8903c4e105f.pdf

© Copyright 2025. All Rights Reserved by MedPath